068270.KS
Price:
$183300
Market Cap:
$40.10T
Celltrion, Inc., together with its subsidiaries, develops and produces therapeutics based on proteins including oncology treatment drugs in South Korea. The company markets Remsima, Truxima, and Herzuma products; generic pharmaceuticals; covid-19 test kits. Its antibody biosimilar pipeline includes CT-P39 for the treatment of asthma and urticaria that is in phase 1 clinical trial; CT-P17 for the treatment of rheumatoid arthritis, psoriatic arthritis, and IBD, which is in phase 3 clinical trial; CT-P16 for the treatment of metastatic colorectal cancer and breast cancer that is in phase 3 clinical trial; CT-P41 for the treatment of osteoporosis and bone loss, which is in phase 1 clinical trial...[Read more]
Industry
Biotechnology
IPO Date
2005-07-19
Stock Exchange
KSC
Ticker
068270.KS
According to Celltrion, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.43. This represents a change of -12.70% compared to the average of 1.64 of the last 4 quarters.
The mean historical Current Ratio of Celltrion, Inc. over the last ten years is 2.25. The current 1.43 Current Ratio has changed 6.28% with respect to the historical average. Over the past ten years (40 quarters), 068270.KS's Current Ratio was at its highest in in the June 2019 quarter at 2.91. The Current Ratio was at its lowest in in the June 2025 quarter at 1.43.
Average
2.25
Median
2.32
Minimum
1.65
Maximum
2.72
Discovering the peaks and valleys of Celltrion, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 27.34%
Maximum Annual Current Ratio = 2.72
Minimum Annual Increase = -13.59%
Minimum Annual Current Ratio = 1.65
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.75 | -13.59% |
| 2023 | 2.03 | -10.44% |
| 2022 | 2.26 | -10.86% |
| 2021 | 2.54 | 6.66% |
| 2020 | 2.38 | -12.33% |
| 2019 | 2.72 | 10.67% |
| 2018 | 2.45 | -6.21% |
| 2017 | 2.62 | 27.34% |
| 2016 | 2.05 | 24.73% |
| 2015 | 1.65 | 2.61% |
The current Current Ratio of Celltrion, Inc. (068270.KS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.01
5-year avg
2.19
10-year avg
2.25
Celltrion, Inc.’s Current Ratio is greater than GeneOne Life Science, Inc. (0.57), less than ALTEOGEN Inc. (1.64), less than SK bioscience Co.,Ltd. (4.48), less than SK Biopharmaceuticals Co., Ltd. (2.19), greater than Genexine, Inc. (0.76), less than D&D Pharmatech (8.70), less than SillaJen, Inc. (16.04), less than Voronoi, Inc. (8.00), greater than OliX Pharmaceuticals,Inc (0.95), less than Peptron, Inc. (22.40),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.57 | $175.34B | |
| 1.64 | $24.40T | |
| 4.48 | $4.23T | |
| 2.19 | $10.49T | |
| 0.76 | $229.22B | |
| 8.70 | $4.16T | |
| 16.04 | $531.80B | |
| 8.00 | $4.28T | |
| 0.95 | $2.37T | |
| 22.40 | $6.62T |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celltrion, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celltrion, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Celltrion, Inc.'s Current Ratio?
How is the Current Ratio calculated for Celltrion, Inc. (068270.KS)?
What is the highest Current Ratio for Celltrion, Inc. (068270.KS)?
What is the 3-year average Current Ratio for Celltrion, Inc. (068270.KS)?
What is the 5-year average Current Ratio for Celltrion, Inc. (068270.KS)?
How does the current Current Ratio for Celltrion, Inc. (068270.KS) compare to its historical average?